Magnetic resonance-guided focused ultrasound of uterine leiomyomas: Review of a 12-month outcome of 130 clinical patients

Journal of Vascular and Interventional Radiology

Volumn 22, Issue 6, 2011, Pages 857-864

  Gorny, Krzysztof R ^a   Woodrum, David A ^a   Brown, Douglas L ^a   Henrichsen, Tara L ^a   Weaver, Amy L ^a   Amrami, Kimberly K ^a   Hangiandreou, Nicholas J ^a   Edmonson, Heidi A ^a   Bouwsma, Esther V ^a   Stewart, Elizabeth A ^a   Gostout, Bobbie S ^a   Ehman, Dylan A ^b   Hesley, Gina K ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF VICTORIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

ABDOMINAL FAT EDEMA; ABDOMINAL SUBCUTANEOUS FAT; ABDOMINAL WALL MUSCULATURE; ADULT; APPLICATION SITE EDEMA; ARTICLE; CANCER PATIENT; CANCER SCREENING; CANCER SURGERY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; EDEMA; ELECTRON SPIN RESONANCE; ENDOMETRIUM ABLATION; ERYTHEMA; FEMALE; FOLLOW UP; GUIDED IMAGERY; HUMAN; HYSTERECTOMY; ISCHIALGIA; LOW BACK PAIN; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MYOMECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS TUMOR; PRIORITY JOURNAL; SUBCUTANEOUS FAT EDEMA; TREATMENT OUTCOME; TUMOR CLASSIFICATION; TUMOR VOLUME; ULTRASOUND; UTERUS MYOMA;

ADULT; BRITISH COLUMBIA; FEMALE; HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION; HUMANS; KAPLAN-MEIER ESTIMATE; LEIOMYOMA; MAGNETIC RESONANCE IMAGING, INTERVENTIONAL; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; TUMOR BURDEN; UTERINE NEOPLASMS;

EID: 79957555764     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2011.01.458     Document Type: Article

References (23)

1. Kjerlulff KH, Erickson AB, Langerberg PW. Chronic gynecologic conditions reported by US women: findings from the National Health Interview Survey, 1984 to 1992. Am J Public Health 1996; 86:195-196.
2. Hill CR, Dunson DB, Hill MC, et al. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 2003; 188:100-107. (Pubitemid 36135604)
3. Graves EJ, Kozak LJ. National hospital discharge survey: annual summary, 1996. Vital Health Stat 13, 1999; 140:i-iv,1-46.
4. Wilcox LS, Koonin LM, Pokras R, et al. Hysterectomy in the United States, 1988-1990. Obstet Gynecol 1994; 83:549-555.
5. Broder MS, Kanouse DE, Mittman BS, Bernstein SJ. The appropriateness of recommendations for hysterectomy in Southern California. Obstet Gynecol 2000; 95:199-205. (Pubitemid 30045640)
6. Verkauf BS. Myomectomy for fertility enhancement and preservation. Fertil Steril 1992; 58:1-15.
7. Spies JB, Asher SA, Roth AR, Kim J, Levy EB, Gomez-Jorge J. Uterine artery embolization for leiomyomata. Obstet Gynecol 2001; 98:29-34. (Pubitemid 32622759)
8. Lumdsen MA, Embolization versus myomectomy versus hysterectomy: which is best, when? Hum Reprod 2002; 17:253-259.
9. Cline HE, Hynynen K, Watkins RD, et al. Focused US system for MR imaging-guided tumor ablation, Radiology 1995; 194:731-737.
10. Tempany CM, Stewart EA, McDannold NJ, et al. MR imaging - guided focused ultrasound surgery of uterine leiomyomas: a feasibility study, Radiology 2003; 226:897-905. (Pubitemid 36259169)
11. Stewart EA, Gedroyc WM, Tempany C, et al. Focused ultrasound treatment of uterine fibroid tumors: safety and feasibility of a noninvasive thermoablative technique Am J Obstet Gynecol 2003; 189:48-54.
12. Stewart EA, Rabinovici J, Tempany CM, et al. Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids Fertil Steril 2006; 85:22-29.
13. Hesley GK, Felmlee JP, Gebhart JB, et al. Noninvasive treatment of uterine fibroids: early Mayo Clinic experience with magnetic resonance imaging guided focused ultrasound. Mayo Clin Proc 2006; 81:936-942. (Pubitemid 43993485)
14. Hesley GK, Gorny KR, Henrichsen TL, et al. A clinical review of focused ultrasound ablation with magnetic resonance guidance. An option for treating uterine fibroids. Ultrasound Q 2008; 24:131-139.
15. Gorny KR, Hangiandreou NJ, Hesley GK, et al. MR guided focused ultrasound: technical acceptance measures for a clinical system. Phys Med Biol 2006; 51:3155-73. (Pubitemid 43885465)
16. Funaki K, Fukunishi H, Fanaki T, et al. Magnetic resonance-guided focused ultrasound surgery for uterine fibroids: relationship between the therapeutic effects and signal intensity on preexisting T2- weighted magnetic resonance images. Am J Obstet Gynecol 2007; 196:184.el-184.e6.
17. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-481.
18. Cox DR. Regression models and life-tables (with discussion). J R Stat Soc Ser B 1972; 34:187-220.
19. Funaki K, Fukunishi H, Sawada K. Clinical outcomes of magnetic resonance-guided ultrasound surgery for uterine myomas: 24 month follow-up. Ultrasound Obstet Gynecol 2009; 34:584-589.
20. Lenard ZM, McDannold NJ, Fennessy FM, et al. Uterine leiomyomas: MR imaging-guided focused ultrasound surgery - imaging predictors of success. Radiology 2008; 249:187-194.
21. LeBlang SD, Hoctor K, Steinberg FL. Leiomyoma shrinkage after MRI-guided focused ultrasound treatment: report of 80 patients. AJR Am J Roentgenol 2010; 194:274-280.
22. Marret H, Cottier JP, Alonso AM, et al. Predictive factors for fibroids recurrence after uterine artery embolization. Br J Obstet Gynaecol 2005; 112:461-465. (Pubitemid 40516561)
23. Spies JB, Myers ER, Worthington-Kirsch R, et al. The FIBROID registry: symptom and quality-of-life status 1 year after therapy. Obstet Gynecol 2005; 106:1309-1318. (Pubitemid 41668951)